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Dehydrogenation of 6,7-dimethoxy-l-methyl-4-(/V-methyl-pyrrolidin-2- Abspaltung der Pyrrolidin-Gruppe bei der Dehydrierung eines 4-
yl)-3,4-dihydroisoquinoline (9) by Pd/C in tetraline leads to dehydrogena- (Pyrrolidin-2-yl)-tetrahydroisochinolins 
ted products, rearrangement, and elimination of the pyrrolidine group 
mainly as N-methylpyrrolidine (Scheme 3). Die Dehydrierung von 6,7-Dimethoxy-l-methyl-4-(A^methyl-pyrrolidin-2-
yl)-3,4-dihydroisochinolin (9) mit Pd/C in Tetralin führt zu dehydrierten 
Produkten, zur Umlagerung und zur Abspaltung der Pyrrolidingruppe 
hauptsächlich als N-Methylpyrrolidin (Schema 3). 
The last step of our synthesis of rac. macrostomine com-
prises dehydrogenation of the pertinent 3,4-dihydroisoqui-
noline increment in 2 by Pd/C in tetraline at 205-210 °C. 
Under these conditions 2 is converted to rac. macrostomine 
(1) and mainly to the 1-benzylisoquinoline 31). 
Sharma and KapiW prepared compound 2 by a different route. They 
quote that a "complex mixture" was obtained by Pd/C-dehydrogenation of 
2, from which 1 was isolated in 20% yield, whilst Wykypiel and SeebachP* 
when dehydrogenating a l,2-dibenzyl-4-(N-formylpyrrolidin-2-yl)-tetrahy-
droisoquinolin-4-ol observed elimination of the benzyl group from C - l as 
a side reaction besides aromatization (note 13 in lit.3)). 
A n analogous cleavage reaction was observed by Winterfeldt et al.4> 
when they tried to dehydrogenate a 4-(l-methyl-pyrrolidin-2-yl)-3,4-dihy-
dro-9//-pyrido[3,4-fc]indole with various oxidative reagents to the perti-
nent harman derivative. 
In order to get some insight into the fate of the pyrrolidine increment the 
volatile components of the dehydrogenation of 2 to 1 were analyzed by 
G C - M S : we found Af-methylpyrroline and traces of N-methylpyrrolidine5). 
However, these compounds are hydrogenated and dehydrogenated under 
these conditions so that no clear-cut view of the cleavage mechanism 
could be obtained5). 
Here we describe dehydrogenation of a 6,7-dimethoxy-l-
methyl-3,4-dihydroisoquinoline, substituted at C-4 with 
pyrrolidine or pyrroline increments (compounds 8 and 9). 
+) Dedicated to Prof. Fleischhacker, Wien, on the occasion of his 60th 
birthday. 
Synthesis 
2-(3,4-Dimethoxyphenyl)-2-(Af-methylpyrrol-2-yl)-ethy-
lamine (4), prepared according to Kapil1) by enamine addi-
tion of N-methylpyrrol to the pertinent co-nitrostyrene and 
hydrogenation of the nitro-group to 4 over Raney-Ni, was 
converted to the acetamide 5. At this stage the pyrrol ring 
was hydrogenated to the corresponding 2,5-dihydro-deriva-
tive 6 by Zn/HCl/MeOH, which, in turn, was fully hydroge-
nated to 7 by H2/Pd/BaS04 in AcOEt. Bischler-Napieralski 
ring closure of the pyrroline 6 led to 8, that of 7 to the pyr-
rolidine-substituted 3,4-dihydroisoquinoline 9. 
Dehydrogenations 
Pyrrolidine 9 was dehydrogenated according to lit.1). The 
mixture of compounds was separated by column chromato-
graphy: Et 20/MeOH (9:1) led to two compounds, then a 
more polar fraction was separated by Et 2 0/MeOH/NH 3 
(20:4:1). 
The compound with the lowest rf-value from the 
Et20/MeOH separation proved to be 6,7-dimethoxy-l-me-
thylisoquinoline (10). The compound with the higher rf-
value was identified as the rearranged molecule 11. The 
formation of this benzo[/]indole might be rationalized as 
depicted in Scheme 4. 
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Dehydrogenation of cpd. 9 leads to an enamine. Allylic/ 
azaallylic hydrogenolysis opens the isoquinoline ring, affor-
ding an imine increment, to which the enamine adds 
nucleophilically with its ß-position. The iminium group is 
stabilized by deprotonation and aromatization - this might 
be the driving force - affording compound 11. 
Among the compounds eluted by the more polar solvent 
6,7-dimethoxy-l-methyl-3,4-dihydroisoquinoline (12) has 
the highest rf-value, followed by the pyrrolidinyl-isoquino-
line 13. The molecule with the lowest rf-value is starting 
material 9. 
As can be seen from Scheme 3, our model compound 9 
loses the pyrrolidine increment (cf. 10 and 12). The 3,4-
dihydroisoquinoline 12 seems to be an intermediate on the 
route to 10, because 12 was dehydrogenated to the isoqui-
noline 10 in a separate experiment under identical condi-
tions. 
When we dehydrogenated the pyrroline derivative 8 under 
our standard conditions, it was aromatized in both ring 
systems leading to the 4-pyrrolylisoquinoline 14 (Scheme 
5). 
This dehydrogenation proceeds remarkably fast: the star-
ting material 8 was consumed already after 20 min. It might 
be speculated that a shift of the double bond in 8 to the 2,3-
position of the pyrroline group facilitates the aromatization 
of the isoquinoline system by a conjugative effect. 
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Volatile components 
In a separate dehydrogenation experiment of 9 we trapped 
the volatile compounds in CDCI3 of -30 °C in a NMR-tube 
cooled by dry ice. A mild stream of dried N 2 was used for 
transportation. By comparison with the spectra of Ä$-N-
methylpyrroline, Af-methylpyrrolidine, Af-methylpyrrol, and 
tetraline we found mainly Af-methylpyrrolidine besides tra-
ces of tetraline. This deviates from the results obtained by 
GC-MS experiments with the macrostromine precursor 25>. 
GC-measurements indicate that iV-methylpyrrolidine is con-
verted in small quantities only to N-methylpyrrol, A3-N-
methylpyrroline disproportionates, and N-methylpyrrol is 
partially di- and tetra-hydrogenated. These results point 
towards a removal of the pyrrolidine increment as N-
methylpyrrolidine. 
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Winterfeldt et al.4> cleaved the pyrrolidine increment in 
their dihydroharman derivative by pivalic acid/trifluoroace-
tic acid. In Winterfeldt's case this H+-catalyzed cleavage of 
the pyrrolidine ring leads to the alkaloid brevicarine. For 
explanation see Winterfeldt4^. - Our compound 9 reacts ana-
logously affording the isoquinoline 15. This indicates that 
this reaction may lead to alkaloids biogenetically related to 
macrostomine (1). 
Moreover, these experiments show that the cleavage 
observed during Pd-catalyzed dehydrogenation of the 
macrostomine-precursor 2 seems to be characteristic for 3-
(pyrrolidin-2-yl)-2,3-dihydropyridins. 
We are thankful to Fonds der Chemischen Industrie for financial support 
of this project. 
Experimental Part 
General remarks: l i t . l b ) .- *H-NMR spectra in CDC1 3 , 5 in ppm. 
N-[2-(N-Methylpyrrol-2-yl)-2-(3A-dimethoxyphenyl)ethyl]-acetamide (5) 
To the mixture of 3.8 g (14.6 mmole) of 2-(3,4-dimethoxyphenyl)-2-(/V-
methylpyrrol-2-yl)-ethylamine (4)2> and 1.5 g (14.9 mmole) E t 3 N in 25 ml 
of absol. CH2CI2, 1.5 g (14.6 mmole) acetic anhydride were added slowly 
drop by drop. Then the mixture was stirred for 1 h at room temp. Excess of 
E t 3 N and its salt were removed by 2N H C l (2 x 10 ml). The org. phase was 
dried (Na 2 S0 4 ) and evaporated in vacuo. The residue was dissolved in 
E t 2 0 and crystallized in the refrigerator: 4.19 g (95%), colourless crystals, 
m.p. 136 °C (EtOH).- C 1 7 H 2 2 N 2 0 3 (302.4) Calcd. C 67.5 H 7.33 N 9.3 
Found C 67.2 H 7.30 N 9.3.- IR (KBr): 3300 (NH), 2840 (NCH 3 ) , 1720 
(CO) cm-*.- i H - N M R : 5 = 1.90 (s; 3H, C O C H 3 ) , 3.30 (s: 3 H . N C H 3 ) , 3.55-
3.75 (m; 2H, C H 2 ) , 3.80 and 3.85 (2 x s; 6H, O C H 3 ) , 4.00-4.20 (m; 1H, 
CH), 5.80 (br. s; 1H, N H , D 20-exchange), 6.10-6.90 (m: 6H, arom.). 
Diastereomeric N-[2~(N-Methyl-A3-pyrrolin-2 -yl)-2-(3 A-dimethoxy-
phenyl)ethyl]-acetamides (6a and 6b) 
To 1.49 (4.9 mmole) acetamide 5, dissolved in 40 ml of MeOH, were 
added 2 g Zn dust. Then a solution of 14.5 ml 36% H C l in 50 ml M e O H 
was added in drops. The mixture was stirred for 30 min and 2 x 2 g Zn 
dust were added during this time. The mixture was diluted with 250 ml of 
water, extracted with 20 ml of C H 2 C I 2 (neutral compounds, discarded), 
basified with cone. N H 3 and extracted again with C H 2 C 1 2 . After drying 
(Na 2 S0 4 ) and evaporation in vacuo the diastereomers were separated by cc 
(S i0 2 ; MeOH/E t 2 0 1:1). 
Diastereomer 6a 
0.88 g (59%), m.p. 98-99 °C (Et 20).- C 1 7 H 2 4 N 2 0 3 (304.4) Calcd. C 67.1 
H 7.90 N 9.2 Found C 67.1 H 7.90 N 9.2.- IR (KBr): 3300 (NH), 2800 
H3CO. 
HjCO 
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( N C H 3 ) , 1725 (CO) c m 1 . - i H - N M R : 8 = 1.90 (s; 3H, C O C H 3 ) , 2.50 (s; 
3H, N C H 3 ) , 2.80-3.90 (m; 6H, 2 x C H 2 , 2 x CH) , 3.95 (s; 6H, O C H 3 ) , 
5.55-5.90 (m; 2H, vinyl.), 6.65-6.80 (m; 3H arom.), 7.45 (br. s; 1H, N H , 
D 20-exch.). 
Diastereomer 6b 
0.44 g (29%), m.p. 137 °C (Et 2 0).- Found C 67.3 H 7.75 N 9.4.- IR 
(KBr): 3300 (NH), 2800 (NCH 3 ) , 1725 (CO) c m ' . - ' H - N M R : 5 = 1.90 (s; 
3H, C O C H 3 ) , 2.40 (s; 3H, N C H 3 ) , 2.65-3.80 (m; 6H, 2 x C H 2 , 2 x CH), 
3.85 (s; 6H, O C H 3 ) , 5.40-5.85 (m; 2H, vinyl.), 6.65-6.95 (m; 3H arom.), 
7.15 (br. s; 1H, N H , D 20-exch.). 
N-[2-(N-Methylpyrrolidin-2-yl)-2-(3,4-dimethoxyphenyl)ethyl]-acetamides 
(7) 
Mixture of diastereomers 1:1 ( 'H-NMR) . 
Method A 
0.5 g (1.7 mmole) of the 1:1 mixture of diastereomeric pyrroline deriva-
tives 6 were hydrogenated in 50 ml of AcOEt over 74 mg Pd/BaS0 4 (5%) 
at room temp, and 1 atm. under stirring until H2-uptake ceased. After f i l -
tration and evaporation 0.46 g (91%) of 7. 
Method B 
The solution of 0.83 g (2.75 mmole) acetamide 5 in 10 ml of glacial ace-
tic acid was mixed with 150 mg Rh/C (5%) and stirred in an autoclave at 
10 bar H 2 for 12 h. After filtration the filtrate was diluted with 80 ml of 
water, basified with 3N NaOH and extracted with C H 2 C 1 2 . The org. phase 
was dried (Na 2 S0 4 ) and evaporated in vacuo: 0.79 g 7 (94%), colourless 
crystals, m.p. range 108-114 °C (Et 2 0).- C 1 7 H 2 6 N 2 0 3 (306.4) Calcd. C 
66.6 H 8.55 N 9.1 Found C 66.5 H 8.46 N 9.1.- IR (KBr): 3300 (NH), 
2800 (NCH 3 ) , 1725 (CO) cm-'.- ' H - N M R : 5 = 1.40-1.80 (m; 4H, N - C H -
CH2-CH2X 1.90 (s; 3H, C O C H 3 ) , 2.35 and 2.40 (2 x s; 3H, N C H 3 ) , 2.40-
3.75 (m; 5H, 2 x C H 2 , CH) , 3.80 and 3.85 (2 x s; 6H, O C H 3 ) , 6.55-6.85 
(m; 3H arom.), 7.60 (br. s; 1H, N H , D 20-exch.). 
J -M ethyl-4-(N-methylpyrrolidin-2 -yl )-6,7-dimethoxy-3,4-dihydroisoquino-
line (9) 
6 g (19.6 mmole) acetamide 7 (1:1 mixture of diastereomers) in 25 ml of 
absol. C H 3 C N were refluxed with 6.5 ml of P O C l 3 for 3 h. Then excess of 
P O C l 3 and solvent were removed in vacuo. The residue was dissolved in 
100 ml of ice water, the solution was basified with 3N NaOH and extrac-
ted with CHC1 3 . After drying (Na 2 S0 4 ) and evaporation the residue was 
purified by cc (S i0 2 ; C H C l 3 / E t O H / N H 3 85:14:1) and subsequent kugelrohr 
distillation: 3.27 g (58%), mixture of diastereomers (1:1), colourless oi l , 
b.p. 150 °C (110-3 torr).- C 1 7 H 2 4 N 2 0 2 (288.4) Calcd. C 70.8 H 8.39 N 9.7 
Found C 70.7 H 8.46 N 9.6.- IR (film): 2800 (NCH 3 ) , 1640 (C=N) c m ' . -
i H - N M R : 5 = 1.45-1.75 (m; 4H, N - C H - C H 2 - C H 2 ) , 2.10 (s; 3H, C - C H 3 ) , 
2.15-4.15 (m; 5H, 2 x C H 2 , CH) , 2.35 and 2.40 (2 x s; 3H, N C H 3 ) , 3.90 
and 3.95 (2 x s; 6H, O C H 3 ) , 6.75 (s; 0.5 H arom.), 6.95 (s; 1H arom.), 7.10 
(s; 0.5 H arom.). 
1-M ethyl-4-(hir-methyl-A3-pyrrolin-2-yl)-6,7T-dimethoxy-3,4-dihydroisoqui-
noline (8) 
2.5 g (8.2 mmole) 6 (mixture of diastereomers 1:1) were reacted as 
described for the preparation of 9.- Purification by cc ( S i 0 2 ; 
E t 2 0 / M e O H / N H 3 20:4:1) and kugelrohr distillation: 1 g (42%) 8, mixture 
of diastereomers 1:1; colourless oil , b.p. 140 °C (1-10-3 torr).- C 1 7 H 2 2 N 2 0 2 
(286.4) Calcd. C 71.3 H 7.74 N 9.8 Found C 71.2 H 7.47 N 9.4.- IR (film): 
2800 (NCH 3 ) , 1640 (C=N) cm-'.- ' H - N M R : 5 = 2.35 and 2.40 (s; 3H, C-
C H 3 ) , 2.50 (s; 3H, N C H 3 ) , 3.10-4.40 (m; 6H, 2 x C H 2 , 2 x CH) , 3.95 (s; 
6H, O C H 3 ) , 5.35-5.85 (m; 2H vinyl.), 6.80 (s; 1H arom.), 7.05 (s; 1H 
arom.). 
Dehydrogenations, general procedure 
0.4 mmole of the pertinent 3,4-dihydroisoquinoIine were dissolved in 5 
ml of tetraline and dehydrogenated under N 2 with 100 mg Pd/C (10%) for 
2 h at 190 ° C - After cooling to room temp, the catalyst was removed by 
filtration and washed with E t 2 0 . Basic compounds were extracted from 
this mixture by 10 ml 2N H C l , the org. phase was discarded. The water 
phase was alkalized by sat. NaHC0 3-solution and extracted with C H 2 C 1 2 . 
This solution was dried (Na 2 S0 4 ) and evaporated in vacuo. Products were 
separated by cc. 
6,7-Dimethoxy-l -methyl-3,4-dihydroisoquinoline (12) 
Cleavage product from 9; cc separation ( S i 0 2 ; E t 2 0 / M e O H / N H 3 
20:4:1), 14%, colourless crystals, m.p. 105 °C (petroleum ether); lit.6>: 108 
° C - C 1 2 H 1 5 N 0 2 (205.3) Calcd. C 70.2 H 7.37 N 6.8 Found C 70.0 H 7.39 
N 6.7.- IR (film): 1640 (C=N) cnr'.- ' H - N M R : 8 = 2.35 (s; 3H, C - C H 3 ) , 
2.65 (t; J = 7.5 Hz, 2H, N - C H 2 - C H 2 ) , 3.65 (t; J = 7.5 Hz, 2H, N - C H 2 ) , 3.95 
(s; 6H, O C H 3 ) , 6.75 (s; 1H arom.), 7.05 (s; 1H arom.). 
6,7-Dimethoxy-l-methylisoquinoline (10) 
Cleavage product from 9; cc separation (S i0 2 ; E t 2 0 / M e O H 9:1), 14%.-
From dehydrogenation of 12: 96%.- Colourless crystals, m.p. 105-106 °C 
(petroleum ether); lit.?): 107-108 ° C - C 1 2 H 1 3 N 0 2 (203.2) Calcd. C 70.9 H 
6.45 N 6.9 Found C 70.5 H 6.50 N 6.8.- ' H - N M R : 5 = 2.85 (s; 3H, C-
C H 3 ) , 4.00 (s; 6H, O C H 3 ) , 7.00 (s; 1H arom.), 7.25 (s; 1H arom.), 7.35 
(AB; J A B = 6 Hz, 1H, H-4), 8.25 (AB; J A B = 6 Hz, 1H, H-3). 
6,7-Dimethoxy-l-methyl-4-(N-methylpyrrolidin-2-yl)isoquinoline (13) 
Cleavage product from 9; cc separation ( S i 0 2 ; E t 2 0 / M e O H / N H 3 
20:4:1), 19%, colourless oil , b.p. 145 °C, 110-3 t 0 r r . - C 1 7 H 2 2 N 2 0 2 (286.4) 
Calcd. C 71.3 H 7.74 N 9.8 Found C 71.2 H 7.49 N 9.6.- IR (film): 2800 
(NCH 3 ) , 1640 (C=N) c m ' . - ' H - N M R : 8 = 1.60-3.30 (m; 7H, pyrr.), 2.40 
(s; 3H, N C H 3 ) , 2.85 (s; 3H, C - C H 3 ) , 4.00 (s; 6H, O C H 3 ) , 7.20 (s; 1H 
arom.), 7.30 (s; 1H arom.), 8.20 (s; 1H, H-3). 
2,3-Dihydro-6,7-dimetho\y-l ,4-dimethylbenzo[f]indol (11) 
Cleavage product from 9; cc separation ( S i 0 2 ; E t 2 0 / M e O H 9:1), 5%; 
colourless crystals, m.p. 156 *C (Et 2 0).- C 1 6 H 1 9 N 0 2 (257.3).- H R - M S : 
Calcd. 257.14156 Found 257.14104.- IR (film): 2810 (NCH 3 ) , 1630 (C=C) 
cm-'.- ' H - N M R : 8 = 2.50 (s; 3H, N C H 3 ) , 2.85 (s; 3H, C - C H 3 ) , 2.90-3.15 
(m; 2H, C H 2 ) , 3.25-3.50 (m: 2H, C H 2 ) , 4.00 (s; 6H, O C H 3 ) , 6.50 (s: 1H 
arom., H-9), 7.00 (s; 1H arom.), 7.20 (s; 1H arom.). 
6J-Dimethoxy-l-methyl-4-(N-methylpyrrol-2-yl)isoquinoline (14) 
By dehydrogenation of 8, purification by cc ( S i 0 2 : E t 2 0 / M e O H / N H 3 
20:4:1), 30%, colourless o i l , b.p. 130 °C, 1- 10-3 torr.- C 1 7 H I 8 N 2 0 2 
(282.3).- IR (film): 2810 (NCH 3 ) , 1620 (C=N) cm-'.- ' H - N M R : 8 = 2.90 
(s; 3H, C - C H 3 ) , 3.45 (s; 3H, N C H 3 ) , 3.90 and 4.05 (2 x s: 6H, O C H 3 ) , 
6.30-6.45 (m; 2H, H - 3 ' , H-4') , 6.80-6.95 (m: 1H, H-5 ') , 7.05 (s; 1H 
arom.), 7.35 (s; 1H arom.), 8.25 (s; 1H, H-3). 
Volatile components from dehydrogenation of 9 
The dehydrogenation was performed as described for the preparation of 
the non-volatile components. Volatile materials were removed from the 
reaction vessel by a slow stream of N 2 and trapped at -30 °C in 1 ml of 
CDCI3 O H - N M R analysis) or 1 ml of C H 3 C N (gc).- GC-conditions: appa-
ratus: Packard-Becker, B . V . (Delft), 428, reconstructed for capillary 
column; FID. Column temp. 250 °C, injector temp. 220 °C, detector temp. 
250 °C. Injections volume 0.01 ml. Split 1:100. Column pressure 0.2 M P , 
H 2 . - Retention times: N-methylpyrrolidine 6.63 min, Af-methylpyrroline 
7.34 min, N-methylpyrrol 14.9 min. 
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